Mechanism and Research Interest

Primary Biological Pathway: Enkephalinase Inhibition The primary mechanism of action for Selank is the inhibition of enkephalin-degrading enzymes (specifically enkephalinase). By preventing the breakdown of leu-enkephalin and other endogenous opioids, Selank effectively extends their half-life in the synaptic cleft. This upregulation of the opioid system results in a potent anxiolytic (anxiety-reducing) effect. Furthermore, research indicates that Selank acts as an allosteric modulator of the GABA-A receptor, enhancing the binding affinity of inhibitory neurotransmitters. The 10mg pen allows researchers to dose-range this effect, exploring how peptide-based modulation differs phenotypically from direct receptor agonism.

Secondary Research Finding: BDNF Expression and Neurotrophy Selank is extensively studied for its impact on neuroplasticity. Experimental data suggests that Selank administration rapidly upregulates the expression of Brain-Derived Neurotrophic Factor (BDNF) in the hippocampus. This neurotrophic support is critical for memory consolidation and cognitive flexibility. Researchers utilise the 10mg format to investigate the peptide’s efficacy in reversing cognitive deficits induced by chronic stress or ischaemia, hypothesising that it promotes dendritic spine density and synaptic repair.

Tertiary Research Finding: Immunomodulation (Tuftsin Heritage) As a derivative of Tuftsin (a peptide produced by the spleen), Selank retains significant immunomodulatory properties. It has been observed to influence the expression of Interleukin-6 (IL-6) and modulate the activity of monoamine neurotransmitters (serotonin, dopamine) in response to immune system challenges. Current studies are examining this “neuro-immune bridge,” specifically how Selank can alter the behavioural response to systemic inflammation (sickness behaviour).

Long-term Genomic and Safety Observations A key differentiator of Selank is its safety profile regarding gene expression in the reward pathways. Unlike traditional anxiolytics, Selank does not alter the expression of genes associated with drug dependence or withdrawal. Genomic toxicology studies are currently verifying that long-term exposure to the 10mg dose does not lead to tolerance or the downregulation of GABAergic receptors, positioning it as a sustainable model for chronic anxiety research.

Product Specifications

• Purity: Validated at >98+% via High-Performance Liquid Chromatography (HPLC). The sequence (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is verified to ensure the Proline-Glycine-Proline C-terminus is intact, which protects the peptide from rapid degradation.

• Appearance: The 3ml pen contains a clear, colourless, sterile liquid.

• Precision: The pen delivery system ensures accurate volumetric dosing, essential for behavioural studies (e.g., Elevated Plus Maze) where dose precision directly correlates with anxiety scores.

• Storage: The product must be stored at 2∘C to 8∘C.

Storage and Shipping Guidelines

Refrigeration and Shelf Life The Selank 10mg Pen is a robust peptide but requires refrigeration (2∘C to 8∘C) to maintain its structural integrity. The shelf life is 12 months in the sealed state. Once the pen is accessed, the bacteriostatic environment preserves the solution for 28 days. While Selank is more stable than many longer-chain peptides, researchers should still aim to utilise the reagent within this window to ensure maximum enzyme-inhibitory potential.

Shipping Stability We utilise medical-grade thermal packaging. The peptide is stable for up to 72 hours at ambient UK temperatures. However, we recommend selecting the fastest available shipping option to minimise environmental exposure.

Freezing Warning Do not freeze. Freezing can cause micro-precipitation of the peptide solution. Upon thawing, the solution may become non-homogenous, leading to inconsistent dosing. A frozen pen should be discarded to ensure experimental validity.

Why Choose the Peptide Pro 3ml Pen Format?

The Selank 10mg Pen offers a significant advantage for Neuro-Behavioural Research. In anxiety and memory studies, the stress of administration can confound results. Traditional vial-and-syringe methods can be stressful for animal subjects.

Our precision pen allows for rapid, low-stress administration, ensuring that the behavioural data reflects the pharmacological action of Selank rather than the procedural stress. It provides a sterile, concentration-verified solution ready for immediate use.

For researchers investigating related neurotrophic or neuropeptide pathways, we recommend examining:

• Semax 10mg: (The ACTH-derived analogue often paired with Selank for comparative cognitive research).

• Oxytocin 10mg: (For comparative studies on social anxiety and trust).

Disclaimer

This product is strictly for Research Use Only (RUO). It is not intended for human consumption, injection, therapeutic use (e.g., for Generalized Anxiety Disorder), or diagnostic procedures. The information provided is for educational and scientific reference only. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and blacklisting, in compliance with UK research chemical regulations.